• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV反式激活因子调控RNA聚合酶II及表观遗传格局,从而对靶免疫细胞进行转录重编程。

HIV Tat controls RNA Polymerase II and the epigenetic landscape to transcriptionally reprogram target immune cells.

作者信息

Reeder Jonathan E, Kwak Youn-Tae, McNamara Ryan P, Forst Christian V, D'Orso Iván

机构信息

Department of Biological Sciences, University of Texas at Dallas, Richardson, United States.

Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, United States.

出版信息

Elife. 2015 Oct 21;4:e08955. doi: 10.7554/eLife.08955.

DOI:10.7554/eLife.08955
PMID:26488441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4733046/
Abstract

HIV encodes Tat, a small protein that facilitates viral transcription by binding an RNA structure (trans-activating RNA [TAR]) formed on nascent viral pre-messenger RNAs. Besides this well-characterized mechanism, Tat appears to modulate cellular transcription, but the target genes and molecular mechanisms remain poorly understood. We report here that Tat uses unexpected regulatory mechanisms to reprogram target immune cells to promote viral replication and rewire pathways beneficial for the virus. Tat functions through master transcriptional regulators bound at promoters and enhancers, rather than through cellular 'TAR-like' motifs, to both activate and repress gene sets sharing common functional annotations. Despite the complexity of transcriptional regulatory mechanisms in the cell, Tat precisely controls RNA polymerase II recruitment and pause release to fine-tune the initiation and elongation steps in target genes. We propose that a virus with a limited coding capacity has optimized its genome by evolving a small but 'multitasking' protein to simultaneously control viral and cellular transcription.

摘要

人类免疫缺陷病毒(HIV)编码反式激活因子(Tat),这是一种小蛋白,它通过结合在新生病毒前体信使核糖核酸(mRNA)上形成的一种RNA结构(反式激活RNA [TAR])来促进病毒转录。除了这种已被充分表征的机制外,Tat似乎还能调节细胞转录,但其靶基因和分子机制仍知之甚少。我们在此报告,Tat利用意想不到的调控机制对靶免疫细胞进行重编程,以促进病毒复制并重塑对病毒有益的信号通路。Tat通过结合在启动子和增强子上的主要转录调节因子发挥作用,而不是通过细胞内的“类TAR”基序,来激活和抑制具有共同功能注释的基因集。尽管细胞中的转录调控机制很复杂,但Tat能精确控制RNA聚合酶II的募集和暂停释放,以微调靶基因的起始和延伸步骤。我们提出,一种编码能力有限的病毒通过进化出一种小而“多功能”的蛋白来同时控制病毒和细胞转录,从而优化了其基因组。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/c7193d3f1df9/elife-08955-fig9-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/6ff8b5a6b9d0/elife-08955-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/3f6f7db22c2e/elife-08955-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/4208a491e4e9/elife-08955-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/8720a5b8384c/elife-08955-fig1-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/4ba8146a718b/elife-08955-fig1-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/7efa117f7481/elife-08955-fig1-figsupp5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/cb89e0facc2f/elife-08955-fig1-figsupp6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/549ae0ac0b2a/elife-08955-fig1-figsupp7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/b97a10285971/elife-08955-fig1-figsupp8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/656359ae47d3/elife-08955-fig1-figsupp9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/072210db9e9d/elife-08955-fig1-figsupp10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/4e816e520c78/elife-08955-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/d11e45f6b70b/elife-08955-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/0cfeca1b816d/elife-08955-fig2-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/78aa618bd904/elife-08955-fig2-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/6546c66d12af/elife-08955-fig2-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/b16d2663f5b8/elife-08955-fig2-figsupp5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/6c3d572b5b79/elife-08955-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/2b0dcfd120c2/elife-08955-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/c60842291a9a/elife-08955-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/d383ac317a23/elife-08955-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/322c6ecf62a7/elife-08955-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/acc6f4729293/elife-08955-fig4-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/593a5a214b82/elife-08955-fig4-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/16389a2e722b/elife-08955-fig4-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/c6b69ea9a2e9/elife-08955-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/c6bf1fd7b2af/elife-08955-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/e576292186cb/elife-08955-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/a49e01105fd3/elife-08955-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/70bae299935e/elife-08955-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/2f840e465c00/elife-08955-fig7-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/c8f5f676224c/elife-08955-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/aee450e89f60/elife-08955-fig8-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/2d32ebea0865/elife-08955-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/c7193d3f1df9/elife-08955-fig9-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/6ff8b5a6b9d0/elife-08955-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/3f6f7db22c2e/elife-08955-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/4208a491e4e9/elife-08955-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/8720a5b8384c/elife-08955-fig1-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/4ba8146a718b/elife-08955-fig1-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/7efa117f7481/elife-08955-fig1-figsupp5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/cb89e0facc2f/elife-08955-fig1-figsupp6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/549ae0ac0b2a/elife-08955-fig1-figsupp7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/b97a10285971/elife-08955-fig1-figsupp8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/656359ae47d3/elife-08955-fig1-figsupp9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/072210db9e9d/elife-08955-fig1-figsupp10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/4e816e520c78/elife-08955-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/d11e45f6b70b/elife-08955-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/0cfeca1b816d/elife-08955-fig2-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/78aa618bd904/elife-08955-fig2-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/6546c66d12af/elife-08955-fig2-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/b16d2663f5b8/elife-08955-fig2-figsupp5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/6c3d572b5b79/elife-08955-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/2b0dcfd120c2/elife-08955-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/c60842291a9a/elife-08955-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/d383ac317a23/elife-08955-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/322c6ecf62a7/elife-08955-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/acc6f4729293/elife-08955-fig4-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/593a5a214b82/elife-08955-fig4-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/16389a2e722b/elife-08955-fig4-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/c6b69ea9a2e9/elife-08955-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/c6bf1fd7b2af/elife-08955-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/e576292186cb/elife-08955-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/a49e01105fd3/elife-08955-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/70bae299935e/elife-08955-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/2f840e465c00/elife-08955-fig7-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/c8f5f676224c/elife-08955-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/aee450e89f60/elife-08955-fig8-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/2d32ebea0865/elife-08955-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a8/4733046/c7193d3f1df9/elife-08955-fig9-figsupp1.jpg

相似文献

1
HIV Tat controls RNA Polymerase II and the epigenetic landscape to transcriptionally reprogram target immune cells.HIV反式激活因子调控RNA聚合酶II及表观遗传格局,从而对靶免疫细胞进行转录重编程。
Elife. 2015 Oct 21;4:e08955. doi: 10.7554/eLife.08955.
2
Tackling Tat.应对反式激活转录蛋白
J Mol Biol. 1999 Oct 22;293(2):235-54. doi: 10.1006/jmbi.1999.3060.
3
The two sides of Tat.反式激活转录物(Tat)的两面
Elife. 2016 Jan 19;5:e12686. doi: 10.7554/eLife.12686.
4
Transfer of Tat and release of TAR RNA during the activation of the human immunodeficiency virus type-1 transcription elongation complex.人类免疫缺陷病毒1型转录延伸复合体激活过程中Tat的转移及TAR RNA的释放
EMBO J. 1997 Sep 1;16(17):5260-72. doi: 10.1093/emboj/16.17.5260.
5
The Tat/TAR-dependent phosphorylation of RNA polymerase II C-terminal domain stimulates cotranscriptional capping of HIV-1 mRNA.RNA聚合酶II C末端结构域的Tat/TAR依赖性磷酸化刺激HIV-1 mRNA的共转录加帽。
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12666-71. doi: 10.1073/pnas.1835726100. Epub 2003 Oct 20.
6
A human splicing factor, SKIP, associates with P-TEFb and enhances transcription elongation by HIV-1 Tat.一种人类剪接因子SKIP与P-TEFb相互作用,并增强HIV-1 Tat介导的转录延伸。
Genes Dev. 2005 May 15;19(10):1211-26. doi: 10.1101/gad.1291705.
7
Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.Tat-Rev对激活细胞中HIV-1复制的调控的数学模型预测了病毒成分合成中振荡动力学的存在。
BMC Genomics. 2014;15 Suppl 12(Suppl 12):S1. doi: 10.1186/1471-2164-15-S12-S1. Epub 2014 Dec 19.
8
Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription.人免疫缺陷病毒1型转录过程中P-TEFb激酶对转录因子磷酸化和组蛋白甲基化的协调作用。
J Virol. 2004 Dec;78(24):13522-33. doi: 10.1128/JVI.78.24.13522-13533.2004.
9
A novel RNA polymerase II-containing complex potentiates Tat-enhanced HIV-1 transcription.一种新型的含RNA聚合酶II的复合物增强了Tat促进的HIV-1转录。
EMBO J. 1999 Jul 1;18(13):3688-701. doi: 10.1093/emboj/18.13.3688.
10
Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein.通过另一种蛋白质与新生RNA相连的HIV-1 Tat蛋白激活转录。
Nature. 1990 Jun 14;345(6276):640-2. doi: 10.1038/345640a0.

引用本文的文献

1
HIV-Tat upregulates the expression of senescence biomarkers in CD4 T-cells.HIV-Tat上调CD4 T细胞中衰老生物标志物的表达。
Front Immunol. 2025 Apr 24;16:1568762. doi: 10.3389/fimmu.2025.1568762. eCollection 2025.
2
HIV Tat as a latency reversing agent: turning the tables on viral persistence.作为潜伏逆转剂的HIV反式激活转录蛋白:扭转病毒持续存在的局面。
Front Immunol. 2025 Apr 11;16:1571151. doi: 10.3389/fimmu.2025.1571151. eCollection 2025.
3
Nuclear warfare: pathogen manipulation of the nuclear pore complex and nuclear functions.

本文引用的文献

1
Architectural and Functional Commonalities between Enhancers and Promoters.增强子与启动子之间的结构和功能共性
Cell. 2015 Aug 27;162(5):948-59. doi: 10.1016/j.cell.2015.08.008.
2
Native elongating transcript sequencing reveals human transcriptional activity at nucleotide resolution.内源延伸转录本测序可在核苷酸分辨率下揭示人类转录活性。
Cell. 2015 Apr 23;161(3):541-554. doi: 10.1016/j.cell.2015.03.010.
3
ChIP-nexus enables improved detection of in vivo transcription factor binding footprints.染色质免疫沉淀结合高通量测序技术(ChIP-nexus)能够更好地检测体内转录因子结合足迹。
核战争:病原体对核孔复合体及核功能的操控
mBio. 2025 Apr 9;16(4):e0194024. doi: 10.1128/mbio.01940-24. Epub 2025 Mar 20.
4
Neuropathogenesis of acute HIV: mechanisms, biomarkers, and therapeutic approaches.急性HIV的神经发病机制:机制、生物标志物及治疗方法
Curr Opin HIV AIDS. 2025 May 1;20(3):199-208. doi: 10.1097/COH.0000000000000923. Epub 2025 Mar 26.
5
Intracellular HIV-1 Tat regulator induces epigenetic changes in the DNA methylation landscape.细胞内HIV-1反式激活因子可诱导DNA甲基化格局发生表观遗传变化。
Front Immunol. 2025 Mar 4;16:1532692. doi: 10.3389/fimmu.2025.1532692. eCollection 2025.
6
Compensatory reactions of B cells in response to chronic HIV-1 Tat exposure.B细胞对慢性HIV-1反式激活蛋白暴露的代偿反应。
J Cell Physiol. 2025 Jan;240(1):e31459. doi: 10.1002/jcp.31459. Epub 2024 Oct 7.
7
Exploring HIV-1 Maturation: A New Frontier in Antiviral Development.探索 HIV-1 成熟:抗病毒药物开发的新前沿。
Viruses. 2024 Sep 6;16(9):1423. doi: 10.3390/v16091423.
8
HIV-1 Tat-Mediated Human Müller Glial Cell Senescence Involves Endoplasmic Reticulum Stress and Dysregulated Autophagy.HIV-1 Tat 介导的人 Müller 胶质细胞衰老涉及内质网应激和失调的自噬。
Viruses. 2024 Jun 3;16(6):903. doi: 10.3390/v16060903.
9
Identification of Three Novel Linear B-Cell Epitopes in Non-Structural Protein 3 of Porcine Epidemic Diarrhea Virus Using Monoclonal Antibodies.利用单克隆抗体鉴定猪流行性腹泻病毒非结构蛋白 3 中的三个新线性 B 细胞表位。
Viruses. 2024 Mar 9;16(3):424. doi: 10.3390/v16030424.
10
Transcriptional regulation of the HIV-1 inhibitory factor human mannose receptor 1 by the myeloid-specific transcription factor PU.1.HIV-1 抑制因子人甘露糖受体 1 的转录调控由髓系特异性转录因子 PU.1 完成。
J Virol. 2024 Jan 23;98(1):e0170223. doi: 10.1128/jvi.01702-23. Epub 2023 Dec 11.
Nat Biotechnol. 2015 Apr;33(4):395-401. doi: 10.1038/nbt.3121. Epub 2015 Mar 9.
4
Histone core modifications regulating nucleosome structure and dynamics.组蛋白核心修饰调节核小体结构和动力学。
Nat Rev Mol Cell Biol. 2014 Nov;15(11):703-8. doi: 10.1038/nrm3890. Epub 2014 Oct 15.
5
Regulation of RNA polymerase II activation by histone acetylation in single living cells.组蛋白乙酰化调控单个活细胞中 RNA 聚合酶 II 的激活。
Nature. 2014 Dec 11;516(7530):272-5. doi: 10.1038/nature13714. Epub 2014 Sep 21.
6
Enhancer loops appear stable during development and are associated with paused polymerase.增强子环在发育过程中似乎很稳定,并且与暂停的聚合酶有关。
Nature. 2014 Aug 7;512(7512):96-100. doi: 10.1038/nature13417. Epub 2014 Jul 2.
7
HIV-1 Tat second exon limits the extent of Tat-mediated modulation of interferon-stimulated genes in antigen presenting cells.HIV-1反式激活因子(Tat)的第二个外显子限制了Tat介导的抗原呈递细胞中干扰素刺激基因的调控程度。
Retrovirology. 2014 Apr 17;11:30. doi: 10.1186/1742-4690-11-30.
8
The Reactome pathway knowledgebase.Reactome 通路知识库。
Nucleic Acids Res. 2014 Jan;42(Database issue):D472-7. doi: 10.1093/nar/gkt1102. Epub 2013 Nov 15.
9
A high-resolution map of the three-dimensional chromatin interactome in human cells.人类细胞三维染色质互作组的高分辨率图谱。
Nature. 2013 Nov 14;503(7475):290-4. doi: 10.1038/nature12644. Epub 2013 Oct 20.
10
Structural insights into transcription initiation by RNA polymerase II.RNA 聚合酶 II 转录起始的结构见解。
Trends Biochem Sci. 2013 Dec;38(12):603-11. doi: 10.1016/j.tibs.2013.09.002. Epub 2013 Oct 11.